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ABSTRACT
Human telomerase reverse transcriptase (hTERT),
the catalytic subunit of human telomerase, contains
conserved motifs common to retroviral reverse
transcriptases and telomerases. Within the C motif
of hTERT is the Leu866-Val867-Asp868-Asp869
tetrapeptide that includes a catalytically essential
aspartate dyad. Site-directed mutagenesis of
Tyr183 and Met184 residues in HIV-1 RT, residues
analogous to Leu866 and Val867, revealed that
they are key determinants of nucleotide binding,
processivity and fidelity. In this study, we show that
substitutions at Val867 lead to significant changes
in overall enzyme activity and telomere repeat
extension rate, but have little effect on polymerase
processivity. All Val867 substitutions examined
(Ala, Met, Thr) led to reduced repeat extension
rates, ranging from »20 to 50% of the wild-type rate.
Reconstitution of V867M hTERT and telomerase
RNAs (TRs) with mutated template sequences
revealed the effect on extension rate was
associated with a template copying defect specific
to template A residues. Furthermore, the Val867
hTERT mutants also displayed increased nucleotide
incorporation fidelity, implicating Val867 as a
determinant of telomerase fidelity. These findings
suggest that by evolving to have a valine at position
867, the wild-type hTERT protein may have partially
compromised polymerase fidelity for optimal and
rapid repeat synthesis.
INTRODUCTION
Telomeres are specialized structures at chromosome
termini consisting of hundreds to thousands of hexanu-
cleotide repeat sequences complexed with several
proteins (1). They prevent chromosome ends from being
perceived as DNA damage, eﬀectively protecting chromo-
somes from degradation and end-to-end joining, thereby
rendering chromosomes stable through successive rounds
of replication. Telomerase is a specialized cellular reverse
transcriptase (RT) employed by eukaryotic cells to restore
telomeric DNA that is lost as a consequence of
chromosomal replication (2). Structurally, telomerase is
a ribonucleoprotein complex, with an RNA-dependent
DNA polymerase activity residing in a protein subunit,
the telomerase reverse transcriptase (TERT), which
utilizes a short, well-deﬁned sequence within an intrinsic
RNA subunit, telomerase RNA (TR), to template the
synthesis of telomeric repeats.
The initial identiﬁcation of the TERT protein compo-
nent of telomerase was facilitated by its homology to
other reverse transcriptases (3,4) including human immu-
nodeﬁciency virus-1 RT (HIV-1 RT). Sequence analysis of
TERT proteins reveals the presence of several of the
conserved motifs important for RT function. Among
these motifs the RT C motif, which contains a common
signature sequence ‘YXDD’ (5–7) shared by all retroviral
reverse transcriptases, has been shown to be one of the
most essential for enzyme activity (8,9). The invariant
aspartates in this motif constitute part of an absolutely
conserved aspartate triad thought to directly participate in
nucleotide addition, coordinated by divalent cations via a
two metal ion mechanism (10). TERT proteins also
contain a triad of invariant aspartates, two of which are
within a ‘hhDD’ (where h¼hydrophobic residue)
sequence in their C motifs analogous to the YXDD
sequence (Figure 1A), that when substituted with alanine
result in completely inactive enzymes (4,11,12). The fact
that these acidic residues are indispensable underscores
their functional importance for telomerase enzymatic
activity and suggests that telomerase may also utilize a
two metal ion mechanism to catalyze polymerization.
In addition to the catalytic role of the aspartate
residues, key roles in other aspects of reverse transcriptase
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residues of the YXDD sequence. Studies on retroviral
RTs (mainly HIV-1 RT) have revealed that these residues
inﬂuence dNTP binding, polymerase processivity, nucleo-
side analog resistance and polymerase ﬁdelity (8,13–18).
The crystallographic structures of binary (enzyme–nucleic
acid) and ternary (enzyme–nucleic acid–nucleotide) com-
plexes of HIV-1 RT place these residues within the active
site in close proximity of the incoming dNTP substrate
and the extending primer terminus (19,20). These struc-
tures show that the ‘X’ amino acid, methionine 184
(Met184) in HIV-1 RT, is positioned against the terminus
of the extending primer such that its side chain interacts
with the base and deoxyribose ring of the terminal
nucleotide. The tyrosine residue, tyrosine 183 (Tyr183)
in HIV-1 RT, is positioned such that its side chain is
intercalated between the terminal and penultimate primer
nucleotides. Thus, the inﬂuence of these residues on HIV-1
RT enzymatic properties stems from the central location
of these amino acids within the catalytic site, where they
can establish multiple contacts with the primer, dNTP and
surrounding dNTP-binding pocket residues.
Little is known about the functional signiﬁcance of the
two residues that precede the conserved aspartates in the
hhDD sequence of TERTs. In mutagenesis studies on
Tetrahymena and yeast TERTs, substitutions at these
residues resulted in enzymes with altered processivities
(21,22). Curiously, Tetrahymena and yeast TERT variants
with substitutions leading to C motifs containing identical
YTDD sequences displayed opposite changes in proces-
sivity, with the Tetrahymena enzyme becoming more
processive and the yeast enzyme less processive.
Although the underlying basis for the divergent eﬀects
of these mutations is unclear, these observations provide
initial indications that these residues, which have major
inﬂuence on retroviral RT function, may also play
important roles in telomerase function. In order to
investigate the involvement of the hydrophobic residues
of the hhDD sequence in human telomerase activity,
we have analyzed the eﬀects of amino acid substitutions in
the C motif LVDD sequence in human TERT (hTERT).
Our studies reveal that mutation of the leucine residue
within the LVDD sequence (leucine 866 (Leu866)) to
tyrosine results in only a slight reduction in enzyme
activity and no changes in polymerase ﬁdelity or repeat
extension rate. Furthermore, unlike Tetrahymena and
yeast TERT mutants, no change in processivity was
observed for hTERT containing the YTDD sequence.
In contrast, substitution at valine 867 (Val867) of the
LVDD sequence resulted in signiﬁcant changes in enzy-
matic activity, nucleotide insertion rate, polymerase
ﬁdelity and telomere repeat extension rate. These ﬁndings
demonstrate that Val867 plays a central role in nucleotide
incorporation by human telomerase and suggest that the
residue may provide important interactions with incoming
substrate nucleotides.
MATERIALS AND METHODS
Oligonucleotides
Oligonucleotide substrates were puriﬁed via denaturing
polyacrylamide gel electrophoresis (PAGE) followed by
gel extraction and ethanol precipitation.
Site-directed mutagenesis ofhTERT
A cassette strategy (23) was used to generate C-motif
mutants of hTERT (Figure 1A). An intermediate vector
was generated from pNFLAGhTERT (23) by PCR in
which the region of hTERT encoding amino acids 864–
871 (containing the C motif) was replaced with a pair of
Sap I endonuclease sites, resulting in a self-excising
sequence. This plasmid, designated pNFLAGhTERT C
del, was digested with SapI, to release the self-excising
segment and generate a vector backbone with cohesive
ends. Pairs of complementary oligonucleotides encoding
speciﬁc amino acid substitutions (for example,
CTCCTGCGTTTGACAGATGATTTCTTG (V867T
Top) and CAACAAGAAATCATCTGTCAAACGCAG
(V867T Bottom) were used to make the mutant V867T)
were phosphorylated, annealed and ligated into the
Figure 1. Sequence alignment of TERT protein C motifs and hTERT
C-motif mutants. (A) Alignment of TERT protein C-motif sequences
from human (36,37), dog (38), mouse (39), rat (GenBank accession no.
AAF62177.1), hamster (40), S. pombe (36), E. cuniculi (41), chicken (42),
frog (43), T. Thermophila (44,45), E. aediculatus (4), O. trifallax (44),
M. crassus (46), C. albicans (EMBL accession no. CAC37831.1) and
S. cerevisiae (4). The HIV-1 RT C-motif sequence (47) is also shown.
(B) Sequences of hTERT C-motif mutants studied in this work.
1156 Nucleic Acids Research, 2007, Vol. 35, No. 4pNFLAGhTERT C del backbone. The resultant con-
structs were transformed, isolated and sequenced to
conﬁrm the presence of the desired changes and the
absence of unintended modiﬁcations.
In vitro reconstitution of human telomerase
Telomerase activity was reconstituted in vitro by coupled
in vitro transcription/translation of hTERT protein in
rabbit reticulocyte lysate (Promega) in the presence of
puriﬁed hTR RNA (23). Reconstitution reactions contain-
ing pNFLAGhTERT (or its C-motif mutant derivatives)
(0.77pmol (0.04mg)/ml) and puriﬁed hTR RNA (0.82pmol
(0.12mg)/ml) were carried out as previously described (23)
and stored at  808C until needed. Aliquots of the
reconstitutions were also analyzed via SDS-PAGE to
quantitate the in vitro synthesized hTERT protein.
Telomerase activity assay
Telomerase activity was measured via a direct primer
extension assay using radiolabeled primer and unlabeled
deoxynucleotides. Primer extension reactions contained
2ml in vitro reconstituted (IVR) telomerase, 1pmol 50 32P
end-labeled substrate primer d(TTAGGG)3, 1mM dATP,
1mM dGTP and 1mM TTP in PE reaction buﬀer
(50mM Tris-Cl pH 8.3, 50mM KCl, 2mM DTT, 3mM
MgCl2 and 1mM Spermidine) in a total volume of 10ml.
Reactions were incubated at 308C for 30min and then
terminated by addition of an equal volume of stop
solution (RNAse A (100mg/ml) in 10mM Tris-Cl pH
8.0, 20mM EDTA) followed by incubation at 378C
for 10min. Reaction products were then isolated and
resolved on 8M urea  10% polyacrylamide gels (23).
Dried gels were then analyzed via phosphoimaging using
ImageQuant software (Molecular Dynamics).
Competitive primer challenge assay
A competitive primer challenge (bind and chase) assay
was used to assess processive DNA synthesis and
measure repeat extension rate (23). IVR hTERT (8ml)
was pre-bound to 5032P-labeled substrate primer
d(TTAGGG)3 (4pmol) in 1  PE reaction buﬀer (total
volume, 24ml) for 5min at 308C. Primer extension
synthesis was then initiated by adding 16mlo f8 0 mM
unlabeled (cold) competitor (chase) primer plus 2.5mM
dATP, 2.5mM dGTP and 2.5mM TTP (in 1  PE salts).
The reaction mixture was incubated at 308C and aliquots
(10ml) were removed at 0.5–30min and synthesis termi-
nated with an equal volume of stop solution. A pre-chased
reaction, where labeled primer (1pmol), unlabeled primer
(160pmol) and dNTPs (1.25mM) in 1.25  PE buﬀer
were combined prior to addition of IVR hTERT (2ml),
was also performed to conﬁrm the eﬀectiveness of the
unlabeled competitor primer. The products of the
primer extension reactions were then processed and
analyzed via standard protocol described earlier for
telomerase activity assay.
Relative enzyme activities and repeat extension rates
were calculated from the quantity and length the modal
product band (23) within the population of radiolabeled
products associated with actively polymerizing complexes,
at a given time point. The population of products
associated with actively polymerizing complexes were
identiﬁed by their ability to be further elongated during
the chase period (e.g. see Figure 3, compare wild type 3
and 30-min lanes). In these studies, the modal product
was determined from the 3-min reaction time point.
This time point allowed for the products of actively
polymerizing complexes to be easily distinguished from
relatively abundant products resulting from low eﬃciency
translocation characteristically seen over the ﬁrst few
rounds of template copying, as well as for accurate size
determination (23).
Repeat extension rate was determined by dividing the
length of the modal band (in number of repeats) by time
(in this case, 3min). Relative enzyme activity was
calculated from the intensity (corrected for background
and normalized against unextended primer) and length
of the modal product band using the following equation:
Relative Enzyme Acitivity ¼
ðLMB   IMBÞ
ðP=100Þ
RMB ,
where LMB¼modal band length (in nt), IMB¼modal
band intensity, P¼Repeat processivity (see later) and
RMB¼number of product repeats in the modal band.
Since all extension products were equally radiolabeled
(i.e. 50 end-labeled), total extension synthesis can be
directly determined from the intensity and length of the
modal product band, adjusting for the eﬀects of enzyme
dissociation by the factor (P/100)
RMB. This adjustment
was necessary because the conditions under which enzyme
activity was assayed (i.e. in the presence of an unlabeled
competitor trap) only allow for the detection of processive
synthesis. However, product synthesis by polymerases
(such as telomerase) can result from either processive
polymerization and/or distributive polymerization. Since
only synthesis resulting from the initial primer–enzyme
binding would be detected, an adjustment factor was
included to account for further primer binding and
extension synthesis by dissociated enzyme that would
normally have been observed in the absence of competitor.
Thus, the observed activity derived from the modal
band intensity (LMB*IMB) was adjusted by an enzyme
dissociation factor ((P/100)
RMB), which was based on the
observed processivity (P).
Repeat processivity was determined from the cumula-
tive product attrition observed over multiple successive
rounds of extension, as measured by the fraction of total
products that have been extended beyond a given repeat.
The fraction of products that are extended beyond a given
repeat is related to repeat processivity by the following
equation:
ER ¼
P
100
 R
,
where ER¼Fraction of total product extension beyond
repeat R, P¼Repeat processivity, R¼repeat number.
Repeat processivities were obtained from ER values
calculated from the ratio of the amount of products
18 standard repeats or greater to the amount of total
Nucleic Acids Research, 2007, Vol. 35, No. 4 1157products (products518 repeatsþproducts418 repeats)
at the 30-min time point. We chose to obtain ER values
from the level of 18th standard repeat to ensure that all
products below this level were no longer capable of further
extension, based on the repeat extension rate of slowest
enzyme being tested (1.39 repeats/min) (Table 2).
Nucleotide exclusion assay
Nucleotide misincorporation by telomerase was
measured via primer extension in the absence of one of
the three substrate nucleotides. Telomerase activity assays
were carried out under standard conditions (as detailed
earlier) except that only two of the three substrate
nucleotides (dATP, dGTP and TTP) were present
(at 1mM) in the extension reaction. Under these condi-
tions, 510% of starting substrate primer is consumed,
ensuring single hit kinetics. In addition, control
reactions were performed where all three substrate
nucleotides necessary for telomere synthesis were present.
Following primer extension, the DNA products of these
reactions were processed as described earlier for the
standard telomerase activity assay and background-
corrected product band intensities obtained via
phosphoimaging.
Nucleotide incorporation ﬁdelity was calculated from
the product band intensities as the ratio of the total
band intensity of products longer than the barrier
product, i.e. the sum of IBþ1þIBþ2þ , etc. to the band
intensity of the barrier product, IB, (i.e. the product
corresponding to copying up to the barrier site).
RESULTS
Enzymatic activity ofC-motif mutants ofhuman TERT
To assess the contribution of the hTERT C-motif residues
Leu866 and Val867 to telomerase enzymatic activity and
function, a panel of hTERT protein mutants was
generated (Figure 1B). These mutants included L866Y,
V867A, M, or T, and, the double substitution mutants
L866Y/V867M and L866Y/V867T. Among these variants
were mutants with substitutions that resulted in hTERT
proteins whose C-motif sequences were converted to
ciliate (LTDD) and yeast (LADD) TERT sequences,
as well as to the HIV-1 RT C-motif (YMDD) sequence.
Reconstituted telomerase complexes were assembled in
rabbit reticulocyte lysates from hTERT protein synthe-
sized in vitro in the presence of puriﬁed, in vitro
transcribed human TR (hTR) RNA. The reconstituted
enzymes were then assayed for telomerase activity in a
direct primer extension assay using radiolabeled telomeric
(d(TTAGGG)3) substrate primer. All of the mutants were
active to some extent (Figure 2, Table 1), although in
every case overall activity was lower than with wild-type
hTERT. While some substitutions resulted in modest
reductions in activity (L866Y) others had severe eﬀects
(V867T) (Table 1). Interestingly, the double substitutions
L866Y/V867M and L866Y/V867T yielded enzymes with
activities at least as active as the single 867M and 867T
substitutions.
Val867 mutants displayaltered product synthesis
In addition to diﬀerences in overall activity, most of
the C-motif mutants displayed two distinct qualitative
diﬀerences in product synthesis. First, the length of the
longest products synthesized by all of the mutants
containing Val867 substitutions was considerably shorter
than those produced by the wild-type enzyme (Figure 2).
This was particularly evident in the telomeric repeat
products of the V867A mutant. Second, the band pattern
of the products synthesized by all of the Val867 variants
was signiﬁcantly diﬀerent from that of wild-type hTERT.
Speciﬁcally, rather than the six-nucleotide ladder char-
acteristic of wild-type synthesis, the ladder of primer
extension produced by the Val867 mutants displayed a
three nucleotide periodicity (Figure 2). A second major
product species presumably representing copying of the
ﬁrst three nucleotides of the template sequence (nucleo-
tides 51CCA49) is seen in addition to the usual major
product which accumulates at the end of a cycle of
template copying. The accumulation of this repeatþ3
(Rþ3) product indicated that reverse transcription had
either slowed down, stalled or the telomerase had
dissociated from the primer substrate completely, after
copying nucleotide A49. Taken together, the appearance
of the Rþ3 products and the observed decrease in the
length of the longest extension products suggested that the
eﬀect of mutation of Val867 on template copying may
result in changes in enzyme repeat extension rate and/or
processivity.
Substitutions at Val867affect repeat extension rate
but notprocessivity
In order to establish whether hTERT C-motif mutations
could inﬂuence the rate of telomere repeat synthesis or
enzyme processivity, primer extension reactions were
performed under competitor challenge (bind and chase)
conditions (Figure 3). When assayed under these condi-
tions both repeat extension rate and processivity can be
readily determined (23). The results of this assay revealed
that all of the mutant enzymes were quite capable of
processive synthesis (compare 3 and 30-min time points).
In fact, the processivities of the mutants, ranging from
 92% (L866Y/V867M) to 99% (V867T) were essentially
equivalent to wild-type hTERT ( 96%) (Table 2).
Table 1. Activity of hTERT C-motif mutants
hTERT Relative activity
a SD
b
WT 1.00 –
866Y 0.66 0.13
867A 0.28 0.07
867M 0.30 0.03
867T 0.15 0.01
YM 0.48 0.05
YT 0.22 0.06
aRelative telomerase activities, expressed as a fraction of wild type,
were determined from competitive primer challenge assays as described
in Materials and Methods section. Activities represent averages of two
independent experiments.
bSD¼Standard deviation.
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(50mM) nucleotide concentration revealed only slight
diﬀerences in processivities amongst the enzymes tested
(Figure 4 and Table 3).
In contrast, substitutions within the C-motif had quite
substantial eﬀects on repeat extension rate (Table 2).
In fact, among the mutants tested, only the L866Y mutant
displayed unaltered repeat extension rate. All hTERT
substitutions involving replacement of Val867 led to
decreases in repeat extension rate, which ranged from
 50% (V867M) to 80% (V867A) reduction in extension
rate compared to wild-type Val867 hTERT. Thus, these
data indicate that the diﬀerence between the length of the
longest products of wild-type hTERT and those of the
Figure 2. Primer extension by hTERT C-motif mutants. (A) In vitro
reconstituted telomerase mutants were assayed for telomerase activity
via direct primer extension as described in Materials and Methods
section. Lysate lane: extension reaction with control IVR containing
RRL only. Unextended d(TTAGGG)3 substrate primer (P) within each
reaction served as loading control (as it represented 495% of the
recovered material). Numbers on left (þ4, þ10, etc.) indicate the
positions of products corresponding to the end of each round of
template copying (expressed as number of nucleotides added to the
primer). Marker sizes (in nucleotides) are indicated. A representative
repeatþ3( Rþ3) product is indicated by arrowhead. (B) Schematic
diagram of major synthesis products from primer extension reactions.
Potential product alignments of Rþ3 and repeatþ6( Rþ6) products
with the template RNA are shown. Nucleotides added during each
round of primer elongation are shown in lower case. hTR nucleotide
positions are indicated next to template sequence.
Figure 3. Competitive primer challenge assay with hTERT C-motif
mutants. Primer extension reactions were carried out under competitor
challenge conditions as detailed in Materials and Methods section.
Following 5-min binding of radiolabeled substrate primer, extension
reactions were initiated and chased with excess cold competitor primer.
Post-chase aliquots were taken at 3 and 30min and analyzed via
PAGE. Pre-chased lane: 30-min extension reaction where excess
competitor primer was added before adding IVR wild-type telomerase.
Lysate lane: extension reaction with control IVR containing RRL only.
Marker sizes (in nucleotides) are indicated. 85nt Rþ3 product band of
V867M telomerase is indicated by an arrowhead.
Nucleic Acids Research, 2007, Vol. 35, No. 4 1159Val867 variants reﬂects reduced repeat extension rate and
not lower processivity.
The competitor-challenge assays also revealed that the
majority of the Rþ3 products associated with primer
extension by the Val867 mutants represent paused
synthesis rather than stalled or terminated polymerization.
A comparison of extension products from the 3 and
30-min reaction time points shows a decrease in the band
intensity of shorter Rþ3 products as the competitor chase
period proceeds (e.g. compare the 85nt Rþ3 band
of V867M, indicated by an arrowhead in Figure 3, 3
and 30-min lanes). The concomitant increase in longer
extension products indicates that most of the Rþ3
products have continued to be elongated, demonstrating
that Rþ3 products are predominantly paused species.
Template copying by V867M hTERT issensitive to dTTP
concentration
The characteristic six-nucleotide ladder of in vitro synth-
esis products observed for wild-type human telomerase
results as a consequence of repeat translocation being
slower and less eﬃcient than template copying. To better
understand the nature of the slowed polymerization that
gave rise to the Rþ3 products, we asked whether Rþ3
accumulation was related to changes in nucleotide
insertion eﬃciency. Speciﬁcally, since template copying
appeared to proceed normally up to residue A49, this
implied that the Val867 mutants were having diﬃculty
inserting a dT residue opposite A48. Therefore, we
examined the eﬀect of dTTP concentration on Rþ3
product formation by Val867 mutants. We chose the
V867M hTERT as a representative Val867 mutant for
these experiments since it was the most active of the single
mutants.
Primer extension assays were performed in the presence
of varied dTTP concentrations and the results are depicted
in Figure 5. As seen from the results of these assays, repeat
synthesis by V867M mutant telomerase was quite sensitive
to dTTP concentration. At 10mM dTTP (the lowest
concentration tested) the mutant enzyme was only capable
of adding a few repeats onto the substrate primer.
In contrast, the wild-type telomerase, while exhibiting
some eﬀects on template copying (see later), was still able
to extend primers with many repeats at the same dTTP
concentration. Furthermore, the proportion of Rþ3
products to total products synthesized by the V867M
mutant was also quite sensitive to dTTP concentration.
As TTP concentration was decreased, Rþ3 products
Figure 4. Competitive primer challenge assay with hTERT C-motif
mutants under reduced nucleotide concentration. Primer extension
reactions were carried out under competitor challenge conditions as
detailed in Materials and Methods section, except that extension
reactions were performed at a dNTP concentration of 50mM rather
than the standard 1mM. Following 5-min binding of radiolabeled
substrate primer, extension reactions were initiated and chased with
excess cold competitor primer. Post-chase aliquots were taken at 3 and
30min and analyzed via PAGE. Pre-chased lane: 30-min extension
reaction where excess competitor primer was added before adding IVR
wild-type telomerase. Marker sizes (in nucleotides) are indicated.
Table 2. Processivities and repeat extension rates of hTERT C-motif
mutants
Processivity
a Extension rate
a
hTERT % SD
b Relative
c Repeats/min SD
b Relative
c
WT 95.79 0.13 1.00 7.33 0.69 1.00
866Y 96.12 2.22 1.00 8.06 0.24 1.10
867A 95.05 1.12 0.99 1.39 0.00 0.19
867M 95.99 1.14 1.00 3.69 0.39 0.50
867T 98.90 0.05 1.03 3.52 0.22 0.48
YM 92.06 1.00 0.96 2.91 0.20 0.40
YT 96.01 0.65 1.00 3.25 0.43 0.44
aProcessivities and extension rates were determined as described in
Materials and Methods section. Processivity values represent averages
of two independent experiments while extension rates represent
averages of three independent experiments.
bSD¼Standard deviation.
cRelative to wild type.
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indicating that the accumulation of Rþ3 products was
the result of impaired dT insertion opposite A48. In fact,
at dTTP concentrations lower than 50mM the Rþ3 band
was the sole major product observed (Figure 5). This was of
particular signiﬁcance as it indicated that at reduced dTTP
concentrations, the rate (and/or eﬃciency) of copying past
A48 is even lower than that of repeat translocation for the
V867M mutant. While the eﬀect of dTTP concentration on
template copying by wild-type hTERT was not as dramatic
as with the V867M mutant, reduced dTTP concentrations
d i dl e a dt ot h ea p p e a r a n c eo fRþ3 product. However,
unlike the mutant, the Rþ3 product was never more
abundant than the full repeat product.
V867M hTERT exhibits atemplate copying defect
specific to template Aresidues
Based on the activity assays it appeared that the reduction
in repeat extension rate was correlated to the diﬃculty
Val867 mutants had copying past residue A48. This raised
the question of whether the copying defect is speciﬁc to
residue A48 (or hTR nucleotide 48) or a general defect
copying template A residues. In order to answer this
question, template copying by V867M hTERT was
examined using a panel of hTR mutants with modiﬁed
template sequences described previously (23). The tem-
plate sequences of these mutant hTRs contained diﬀerent
substitutions within the template sequence 49AAU47,
resulting in sequences with zero to three template A
residues (Figure 6A). Four out of the ﬁve mutants
that were tested contained A48U substitutions. In addi-
tion, as these hTR template mutants were designed to
allow for eﬃcient processive repeat synthesis, the align-
ment sequences (nucleotides 55AAU53) in these mutants
were also modiﬁed to reﬂect the changes to the templating
nucleotides (49AAU47) (Figure 6A).
Telomerase complexes were assembled in vitro with
V867M hTERT and each individual mutant hTR and the
reconstituted telomerases assayed for activity. Primer
extension reactions were performed under competitor
challenge conditions to allow for measurement of repeat
extension rate, as well as for discrimination of slowed
synthesis from stalled/terminated primer elongation.
These assays revealed that V867M hTERT was capable
of eﬃcient repeat synthesis using each of the mutant
templates (Figure 6B). Similar to previous observations
with wild-type hTERT (23), repeat synthesis with the
mutant template RNAs was processive, as evidenced by
the high proportion of actively engaged primer substrate
being further elongated during the chase period
(Figure 6B). Moreover, extension rate measurements
(Table 4) indicated a clear inﬂuence of template sequence
on V867M telomerase extension rate. Interestingly, each
of the mutant hTRs reconstituted enzymes with increased
extension rates compared to V867M hTERT reconstituted
with wild-type hTR. This was not entirely unexpected as
we have previously shown with wild-type hTERT that
template sequence can aﬀect the repeat extension rate (23).
However, it was surprising that in the majority (four out
of ﬁve) of the cases, the relative changes in extension
rate seen with the V867M hTERT/mutant hTR enzymes
did not parallel the changes observed with wild-type
hTERT/mutant hTRs. Speciﬁcally, reconstitution of
V867M hTERT with MH1, MH2, MH3 and MH5
hTRs led to extension rates that were 2.14 , 2.23 ,
3.94  and 1.41  faster, respectively, than wild-type hTR
(Table 4). In contrast, reconstitution of wild-type hTERT
with MH1, MH2, MH3 and MH5 hTRs yielded enzymes
whose extension rates were 0.85 , 1.17 , 1.97  and
1.76  as fast as the rate of wild-type hTERT with wild-
type hTR (Table 4). If it is assumed that the relative
diﬀerences in telomerase extension rate between enzymes
assembled with wild-type or mutant hTRs are inherent to
the template sequence, then these diﬀerences should
be constant regardless of the hTERT in the complex.
Yet, a distinct hTERT-speciﬁc modulation of template
sequence-governed extension rate is evident, which can be
expressed as the ratio of 867M extension rate/wild-type
extension rate (867MEXT/867VEXT) (Table 4). When
expressed as 867MEXT/867VEXT values, one ﬁnds the
mutant TERT has no eﬀect on the inherent extension rates
of the MH2 and MH3 hTRs, (ratios 1), slight increase of
MH1 rate (ratio¼1.28) and substantial decrease of
extension rates of MH4, MH5 and wild-type hTRs
(ratios¼0.54, 0.4 and 0.50, respectively). Conversely,
considered from the perspective of template utilization,
the V867M and wild-type enzymes performed repeat
synthesis at the same rates with the MH2 and MH3
hTRs, nearly the same with MH1 but substantially
diﬀerent with MH4, MH5 and wild-type hTRs.
Furthermore, 867MEXT/867VEXT values appear to corre-
late with template A residue content. The MH1, MH2 and
MH3 hTRs which contain the fewest (0–1) template A
bases had the highest 867MEXT/867VEXT values, the MH5
hTR, with three A residues, had the lowest ratio while the
WT and MH4 hTRs, with two A residues, had inter-
mediate ratios (Table 4). These data indicate increasing
template A content results in reduced repeat extension rate
for V867M telomerase.
While it is possible that diﬀerences in extension rates
seen with the mutant templates may reﬂect substrate
alignment or aﬃnity diﬀerences, it is likely that altered
Table 3. Processivities of hTERT C-motif mutants under reduced
nucleotide concentration
Processivity
a
hTERT % Relative
b
WT 84.19 1.00
866Y 86.72 1.03
867A ND
c ND
c
867M 81.63 0.97
867T 77.33 0.92
YM 67.24 0.80
YT 80.45 0.96
aProcessivities were determined as described in Materials and Methods
section, except that ER values were calculated from the 4th standard
repeat rather than the 18th standard repeat. Processivity values were
obtained from reactions shown in Figure 4.
bRelative to wild type.
cNot determined.
Nucleic Acids Research, 2007, Vol. 35, No. 4 1161Figure 5. Eﬀect of dTTP concentration on primer extension activity. Primer extension synthesis by wild type and V867M telomerases was measured
in primer extension reactions in the presence of increasing concentrations of TTP. Extension reactions containing 1mM dATP, 1mM dGTP and
TTP at the concentration indicated, were performed under standard conditions as detailed in Materials and Methods section. Representative repeat,
R, as well as Rþ3 and Rþ6 products are indicated, along with potential product alignments with template RNA at right. Nucleotides added during
each round of primer elongation are shown in lower case. hTR nucleotide positions are shown next to template sequence. Both wild type (left) and
V867M (right) panels are from the same gel.
1162 Nucleic Acids Research, 2007, Vol. 35, No. 4Figure 6. Eﬀect of hTR template sequence on primer extension by 867M hTERT. (A) Wild type and V867M hTERT proteins were reconstituted
with wild type and template mutant (MH) hTR RNAs (23) shown. (B) Primer extension reactions were carried out under competitor challenge
conditions as detailed in Materials and Methods section. Post-chase aliquots were taken at 3 and 30min and analyzed via PAGE. Pre-chased lane:
30-min extension reaction where excess competitor primer was added before adding IVR wild-type telomerase. Lysate lane: extension reaction with
control IVR containing RRL only. (C) Enlarged view of region between 48 and 75nt. Sequence of the WT hTR template (nucleotides 46–51) is
shown along with the sequence of the wild-type product. The number of nucleotides added onto a previously copied full repeat is indicated in
parentheses. Arrowheads indicate product accumulation prior to copying a template A residue.
Nucleic Acids Research, 2007, Vol. 35, No. 4 1163substrate aﬃnity or alignment would only aﬀect initial
binding of substrate primer and not extension synthesis.
This is because once the mutant template is copied, the
nascent product is completely complementary to both
the alignment and templating (copied) nucleotides of the
mutant template (as indicated in Figure 6A). Thus,
repeat extension rates would more probably be inﬂuenced
by product synthesis (template copying) and translocation
rates rather than substrate aﬃnity or initial alignment.
The patterns of extension products further corroborated
the conclusion that in general, polymerization slows
down when template A bases are encountered by V867M
telomerase. For example, signiﬁcant product accumulation
isobservedpriortocopyingpastA49oftheMH3template,
A49 (and to some extent A47) of the MH4 template and
A49, A48 and A47 of the MH5 template (Figure 6C,
arrows) in addition to products seen when the modiﬁed
templates are copied by wild-type hTERT (23). In fact, the
Rþ2 products (which result from impeded copying past
A49) predominate in the MH4 pattern, indicating that
withtheMH4templatetherateofpolymerization pastA49
is even slower than the rate of repeat translocation.
In contrast, copying of the MH1 and MH2 templates,
which lack template A residues, did not reveal any speciﬁc
new sites of substantial product accumulation when
compared to copying by wild-type hTERT (these mutants
produce weak band patterns with wild-type hTERT (23)).
These results indicate that the template copying defect
displayed by V867M hTERT appears to be primarily
a general defect in copying past template A residues.
However, additional factors appear to modulate this
defect. Although both wild type and MH4 templates
possess two A residues, polymerization past only one
(A48 in wild type and A49 in MH4) seemed particularly
impaired (Figure 6C). Thus, these observations suggest
that there is at least a partial eﬀect of template position
and/or sequence context on the copying defect.
Val867hTERT mutants display increased nucleotide
incorporation fidelity
Since it has been well established that the HIV-1 RT
counterparts of Leu866 and Val867 (Tyr183 and Met184)
are key ﬁdelity determinants, it seemed logical that
hTERT C-motif mutants might display altered ﬁdelities.
We chose to measure the ﬁdelity of the mutants via a
nucleotide exclusion assay. In this assay, primer extension
reactions are carried out where either all three substrate
nucleotides (dATP, dGTP and TTP) are present or one of
the three is omitted (excluded) from the reaction. Under
conditions of single nucleotide exclusion, faithful template
copying proceeds until the ﬁrst template position requiring
the incorporation of the absent dNTP is encountered.
Any polymerization opposite or beyond this ‘barrier’ site
results from misincorporation of incorrect nucleotides.
Thus, measurement of synthesis beyond a barrier site
provides an index of polymerase ﬁdelity.
Nucleotide exclusion assays were performed with the
Leu866 and Val867 mutant telomerases. In reactions
where TTP was excluded, little diﬀerence could be
discerned between the wild type and mutant enzymes.
Synthesis beyond the barrier site in these reactions
appeared as a single nucleotide ladder extending approxi-
mately 12nt (data not shown). However, it is likely that
this ladder represents strand slippage synthesis rather
than incorrect nucleotide incorporation. Studies on
Tetrahymena telomerase have demonstrated that similar
ladders, composed of poly-(dG), are synthesized in the
absence of TTP (24,25), and they are presumed to be the
products of strand slippage copying within the template
homopolymeric C run.
In contrast, reactions lacking dATP or dGTP, revealed
major diﬀerences in post-barrier site synthesis. With the
exception of the L866Y mutant, all of the mutants
exhibited signiﬁcantly lower primer extension past both
the ‘U’ barrier site (U47) and the ‘C’ barrier site (C46)
compared to wild-type hTERT (Figure 7). In the absence
of dATP both wild type and L866Y telomerase could
repeatedly extend beyond the U47 barrier position
(Figure 7A, WT and L866Y  dA lanes) leading to
extension products of over 150nt (data not shown).
Under identical conditions, template copying of U47 by
all mutants containing Val867 substitutions was much
less eﬃcient, with essentially no extension proceeding
beyond the third encounter of the barrier (Figure 7A,
 dA lanes). The Val867 mutants were also less eﬃcient
than wild type or the L866Y mutant at primer extension
past U47 in the absence of dGTP (Figure 7B and C,
compare  dG lanes). Careful examination of
Table 4. Extension rate of V867M hTERT reconstituted with hTR template mutants
V867M Wild type
a
HTR Repeats/min SD
b Relative
extension rate
c
Repeats/min SD
b Relative
extension rate
c
867MER/867VER
d Template A
residues
WT 3.69 0.39 1.00 7.33 0.69 1.00 0.50 2
MH1 7.97 0.12 2.14 6.22 0.22 0.85 1.28 0
MH2 8.56 0.47 2.23 8.56 1.17 1.17 1.00 0
MH3 14.06 0.71 3.94 14.46 1.75 1.97 0.97 1
MH4 8.06 1.18 2.41 15.06 1.90 2.05 0.53 2
MH5 5.14 0.12 1.41 12.93 0.80 1.76 0.40 3
aData for the wild type is taken from Drosopoulos et al. (23).
bSD¼Standard deviation.
cExtension rates are expressed relative to wild-type hTR for the given hTERT.
dRatio of extension rate of 867M hTERT to extension rate of 867V hTERT. Rates represent averages of two independent experiments.
1164 Nucleic Acids Research, 2007, Vol. 35, No. 4the post-barrier synthesis products of both dATP and
dGTP-excluded reactions (Figure 7A and B) reveals a
shift in migration relative to the corresponding
products of reactions with all nucleotides present,
indicative of true misincorporation.
A quantitative measure of ﬁdelity, calculated from the
ratio of the amount (band intensity) of barrier product
(i.e. product corresponding to copying up to the barrier
site) to the amount of products longer than the barrier
product, is presented in Table 5. We chose to quantify
ﬁdelity from the dGTP-excluded assays since copying
opposite or beyond the C46 barrier site in these reactions
was limited to only two main products, Pþ4 and Pþ5
(the two template positions copied following C46
(i.e. C51 and C50) are also C residues), facilitating
accurate measurement. Based on the ﬁdelity value
obtained for the wild-type telomerase (Table 5), almost
45% of primer extended to the barrier site by the enzyme
was further elongated via nucleotide misincorporation.
All of the Val867 substituted enzymes, in contrast,
exhibited signiﬁcantly lower misincorporation synthesis
which was reﬂected in increased ﬁdelities, that ranged
from 2.2-fold (V867T) to 13.5-fold (L866Y/V867M)
higher than wild type (Table 5). These ﬁndings demon-
strate that the Val867 residue in hTERT is a determinant
of telomerase polymerase ﬁdelity.
DISCUSSION
Although telomerase is a quite specialized reverse
transcriptase, with regard to catalysis, it is likely that
polymerization by telomerase is mechanistically similar to
other RTs. Like other RTs, absolutely conserved aspartate
residues within conserved RT motifs are essential for
telomerase’s RNA-dependent DNA polymerase activity.
Furthermore, mutation of conserved residues in RT
motifs 1, 2 and A of Tetrahymena TERT lead to activity
changes that can be rationalized from the roles played
by the equivalent retroviral RT amino acids in the active
site dNTP-binding pocket of RT (26). The implication
from such observations is one of common structure/
function relationships for homologous residues in TERT
and other RTs. Consistent with this view, we identify
here an amino acid in hTERT that functions as a
determinant of polymerase ﬁdelity, a role it shares with
its counterpart in HIV-1 RT.
In HIV-1 RT Tyr183 and Met184, the cognate amino
acids to hTERT Leu866 and Val867, play direct roles in
enzymatic activity, processivity, ﬁdelity, dNTP utilization
and nucleoside analog inhibitor resistance (8,13,14,17,18).
We ﬁnd that only Val867 has signiﬁcant inﬂuence
on several of these properties in human telomerase,
speciﬁcally, enzymatic activity, dNTP utilization and
ﬁdelity. Mechanistically, these properties can all be related
through nucleotide incorporation eﬃciency. Overall
enzymatic activity is dependent on eﬃcient dNTP
incorporation while the ﬁdelity of DNA synthesis is
related to the eﬃciency that an incorrect nucleotide can
be incorporated. Thus, our ﬁndings indicate that Val867
plays a key role in nucleotide incorporation and suggest
that this residue may provide important interactions with
incoming substrate nucleotides.
Structural models of wild type and nucleoside analog-
resistant Met184Ile and Met184Val mutant HIV-1 RTs
may oﬀer some insight into possible nature of Val867
Figure 7. Nucleotide exclusion assay with hTERT C-motif mutants.
Primer extension reactions were performed under standard conditions
with all three substrate nucleotides (dATP, dGTP and TTP) present
(þall), only dGTP and TTP present ( dA), or only dATP and TTP
present ( dG) in the extension reaction. The sequence of correctly
copied product along with the number of nucleotides added to the
radiolabeled primer (P ) is indicated. (B) Lower exposure of (A).
Expected full-length products of accurate extension synthesis in the
absence of dATP ( dA product) and dGTP ( dG product) are shown,
with newly copied nucleotides in lower case. The number of nucleotides
added to the radiolabeled primer resulting from extension by
telomerase is indicated in parentheses.
Table 5. Fidelity of hTERT C-motif mutants
hTERT Fidelity
a Relative ﬁdelity
WT 0.82 1.0
866Y 0.85 1.0
867A 0.21 3.9
867M 0.16 5.2
867T 0.38 2.2
867YM 0.06 13.5
867YT 0.29 2.8
aValues were calculated from the  dG reaction products shown in
Figure 7B.
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chain of Met184 projects into the active site between the
primer terminal nucleotide and the incoming dNTP.
However, the side chain only contacts the primer
30 terminus (19,20). Crystallographic and computer-
generated structures of isoleucine- and valine-substituted
b-L-nucleoside analog-resistant mutants indicate that the
methyl group of these b-branched side chain residues
protrudes into the dNTP-binding pocket and creates an
additional contact with the dNTP sugar ring (20,27,28).
Consequently, a more sterically constrained dNTP-
binding pocket would result that is unable to accommo-
date the unnatural L-conformation nucleoside rings of
b-L-nucleoside inhibitors, but still able to eﬃciently
incorporate normal b-D-dNTPs. If the side chain of
Val867 were positioned similarly in the active site of
hTERT then it would be making contact with the sugar
ring of the incoming dNTP. A requirement for such a
contact could furnish a possible explanation for the
eﬀects of Val867 mutations on hTERT function.
In wild-type hTERT the Val184 side chain–dNTP inter-
action may aid in proper dNTP positioning and/or add
stability to the dNTP–enzyme complex, resulting in
eﬃcient nucleotide utilization. Substitution with alanine
or methionine removes this interaction and while threo-
nine substitution maintains the side chain b-methyl
branch, interactions of its polar hydroxyl with the
primer terminus may prevent proper positioning of the
methyl group (Figure 8). The absence of this contact
would make dNTP binding and incorporation more
dependent on the remaining dNTP–enzyme interactions
such as Watson–Crick hydrogen bonding and base
stacking. Increased dependence on proper Watson–Crick
bonding would result in increased nucleotide insertion
ﬁdelity, as was observed for all Val867 substitutions.
It could also partially account for the speciﬁc reduction in
TTP utilization eﬃciency seen in these mutants.
Furthermore, the lack of residue 867–dNTP sugar
interactions may account for the similar reduction in
overall activity exhibited by the methionine mutant,
which has signiﬁcant potential for interactions by virtue
of its long side chain, and the alanine mutant, whose short
side chain aﬀords it much less interactive capacity.
Our studies reveal that substitution of Val867 with
other amino acids, particularly methionine, increases
the ﬁdelity of DNA synthesis by hTERT (Table 5).
Curiously, we and others (13,14) have found the reverse
substitution in HIV-1 RT, M184V, also increases its
nucleotide insertion ﬁdelity. Furthermore, while alanine
substitution of Val867 led to increased ﬁdelity in hTERT,
the M184A HIV-1 RT variant displayed markedly
reduced ﬁdelity (14). The opposite eﬀects of these
comparable substitutions, along with the similar eﬀects
of the reverse Val/Met mutations, point to distinct
diﬀerences in the nucleotide-binding pockets of hTERT
and HIV-1 RT. Structural data and modeling indicate
M184V substitution leads to a more closed dNTP-binding
site (see above). Because of the presence of the side chain
b-methyl group, greater steric demand is imposed on the
incoming dNTP for proper base-pair geometry and this
in turn may result in the observed increase in ﬁdelity.
This would imply that the Val867 b-methyl branch in
hTERT may not generate as much of a steric constraint
on the dNTP-binding pocket and therefore less steric
selection pressure on the incoming dNTP. Moreover,
this would suggest that hTERT has a more open
nucleotide-binding site than HIV-1 RT, with Val867
positioned further from the dNTP substrate than
Val184. A relatively more open active-site geometry
would support our proposed explanation of the eﬀects
of hTERT Val867 substitutions. Alternatively, the diﬀer-
ences in the eﬀects of Val867 and Met184 mutations on
ﬁdelity may be the result of diﬀerences in primer/template
repositioning along with smaller alterations in the dNTP-
binding pocket.
One of the consequences of Val867 mutation was
reduced repeat extension rate (Table 2). The underlying
basis for this appears to involve a general template
copying defect speciﬁc to template A residues linked to
impaired TTP utilization. Interestingly, our studies with
varied hTR templates (Figure 6C) revealed that pausing in
templates with multiple A residues (such as wild type) did
not always occur equivalently at all A residues.
Furthermore, pausing did not always occur at common
A residue sites (e.g. A49) (Figure 6C, compare WT to
MH3, MH4 and MH5 templates) suggesting eﬀects of
template position and/or sequence context. If template
position is modulating the copying defect then this would
suggest that hTERT active site geometry changes as the
Figure 8. Schematic representation of hTERT residue 867 substitutions.
Potential orientations of the side chains of the Val (wild type),
Met, Thr, Ala 867 residues within the active site of hTERT are
depicted. These orientations were generated by mutating the analogous
HIV-1 RT residue Met184 in the HIV-1 RT ternary complex structure
using the published coordinates (PDB1RTD) of Huang et al. (20).
Individual substitutions (M184V, A, or T) were created in the published
HIV-1 RT structure using the DeepView/Swiss-pdbViewer program.
The ‘best’ ﬁt rotamers are presented.
1166 Nucleic Acids Research, 2007, Vol. 35, No. 4template traverses the active site. This appears to be
consistent with studies on nucleoside analog utilization by
Tetrahymena telomerase (29), where a similar explanation
was used to account for template position-speciﬁc
diﬀerences in the eﬃciency of analog incorporation.
Another curious ﬁnding was that mutation of either
Leu866 or Val867 had no or very limited eﬀect on hTERT
processivity. Based on previous reports that substitution
at homologous sites in other RTs result in signiﬁcant
changes in processivity, one could have expected that the
YTDD substituted hTERT would display altered proces-
sivity, similar to the equivalent yeast and in vitro
reconstituted Tetrahymena mutants. One explanation for
the absence of such eﬀects may lie in the inherently high
processivity of human telomerase. In contrast to yeast
and in vitro reconstituted Tetrahymena telomerases,
in vitro reconstituted (and native) wild-type human
telomerase is almost completely processive in in vitro
assays ((30); this work, Table 2). This likely reﬂects
multiple important contributions by several regions in the
enzyme including the anchor region (31–33) and the TR
pseudoknot and template elements (34) to human
telomerase processivity. While these features are not
unique to human telomerase, it may not be merely
their presence but the strength of their contribution to
product–enzyme complex stability that is particularly
substantial. For example, some of the highly conserved
TR elements, e.g. the pseudoknot (CR2–CR3) and
CR4–CR5 (Helix IV) domains, are considerably larger
in hTR as compared to Tetrahymena TR. This aﬀords
these elements more potential sites for interaction in
human versus Tetrahymena telomerase. Thus, it is possible
that in human telomerase the contributions of these
(and/or other) elements to processivity are particularly
signiﬁcant and can eﬀectively compensate for the loss of
primer–Leu866/Val 867 interactions.
Mutation of Val867 leads to reductions in overall
enzyme activity and eﬃciency of TTP utilization, resulting
in reduced repeat extension rate, yet increased polymerase
ﬁdelity. Based on these observations, it appears that the
hTERT protein has evolved to have valine at 867 because
it is optimal for activity and rapid repeat synthesis, even at
the cost of polymerase ﬁdelity. The in vitro error rate of
human telomerase has been estimated to be 2 10
 3 per
nucleotide or one non-canonical repeat per hundred
normal repeats (35). Presumably, the level of ﬁdelity
aﬀorded by Val867 is suﬃcient to maintain the minimal
telomere sequence integrity necessary for speciﬁc recogni-
tion by telomere-binding proteins.
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